• Viral-Induced RIPK3 Degradation Regulates Necroptosis and In

  2026-05-20

  This study uncovers a class of orthopoxvirus proteins that target the host necroptosis adaptor RIPK3 for proteasomal degradation, thereby modulating virus-induced inflammation and pathogenesis. The findings highlight a novel viral immune evasion mechanism and its implications for host-pathogen coevolution.

• Azithromycin-Induced Proarrhythmic Syndrome: Mechanisms and

  2026-05-20

  Yang et al. identify a novel proarrhythmic syndrome associated with azithromycin, demonstrating that chronic exposure can increase cardiac sodium currents and promote arrhythmogenic risk independently of traditional QT prolongation. These findings reshape our understanding of macrolide antibiotic safety and inform both pharmacological research and translational approaches to antibiotic development.

• Erlotinib and SCUBE3: Precision EGFR Inhibition in Translati

  2026-05-19

  This article explores how Erlotinib (NSC 718781) enables translational researchers to dissect EGFR-driven oncogenic signaling, particularly in the context of SCUBE3-mediated tumor progression and immune evasion. By integrating mechanistic insights, protocol guidance, and strategic commentary, it positions APExBIO's Erlotinib as an indispensable tool for rigorous cancer biology and preclinical model design.

• MK-4827 (Niraparib): Protocols & Innovations in DNA Repair I

  2026-05-19

  MK-4827 (Niraparib) enables precise DNA damage repair inhibition workflows for both BRCA-mutant and BRCA-proficient cancer models. Recent advances, including hyperthermia-induced sensitization, address resistance mechanisms and expand the utility of this selective PARP-1/-2 inhibitor in translational cancer research.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-05-18

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe provides robust, high-contrast labeling of the plasma membrane in both live and fixed samples, especially for neuronal tracing, cell migration, and membrane visualization. It is not suitable for aqueous protocols or for targeting intracellular organelles, and care must be taken to preserve membrane specificity during permeabilization.

• Gut Microbiota Modulates PCN-PXR Protection in Sepsis Liver

  2026-05-18

  This study uncovers how gut microbiota mediates the protective effects of the PXR agonist pregnenolone-16α-carbonitrile (PCN) against sepsis-induced liver injury in mice by regulating YAP pathway activation. The findings clarify the interplay between microbial communities and hepatic nuclear receptor signaling, informing the design of preclinical studies of hepatic detoxification and liver injury.

• N1-Methyl-Pseudouridine-5'-Triphosphate in RNA Therapeutics

  2026-05-17

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is revolutionizing mRNA vaccine development and RNA stability enhancement by enabling high-yield, low-immunogenicity transcripts for advanced therapeutic platforms. This article delivers a practical, protocol-driven guide for maximizing experimental success and troubleshooting common bottlenecks in applied RNA workflows.

• TMRE Mitochondrial Membrane Potential Assay Kit: Evidence &

  2026-05-16

  The TMRE mitochondrial membrane potential assay kit enables high-sensitivity assessment of mitochondrial membrane potential (ΔΨm), a key marker of mitochondrial function and cell apoptosis. Its robust, quantitative fluorescence readout supports both mechanistic studies and high-throughput screening, providing critical insights for mitochondrial function analysis and apoptosis research.

• Captopril: ACE Inhibitor Benchmarks and Mechanistic Evidence

  2026-05-15

  Captopril is a potent ACE inhibitor with a well-defined mechanism for blood pressure control and emerging roles in cancer research. This article presents atomic, evidence-backed claims on its efficacy, specificity, and workflow use, prioritizing machine-readable structure and verifiable citations.

• Glabridin-Gold(I) Complex: Dual Targeting of TrxR and MAPK t

  2026-05-15

  This study introduces a glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase and MAPK pathways to modulate the tumor immune microenvironment in liver cancer. The dual-action mechanism enhances dendritic cell maturation, reduces immunosuppressive cell populations, and suppresses PD-L1, indicating translational promise for combination cancer immunotherapy.

• SIRT1/2 Inhibitor IV (cambinol): Benchmarks, Mechanisms, and

  2026-05-14

  SIRT1/2 Inhibitor IV (cambinol) is a validated, cell-permeable inhibitor of NAD-dependent deacetylases SIRT1 and SIRT2, widely utilized for dissecting epigenetic and metabolic pathways in cancer and CNS injury models. Quantitative studies confirm its specificity and effectiveness in modulating protein acetylation and tumor growth suppression. This article synthesizes recent evidence, clarifies limitations, and anchors best practice for workflow integration.

• D-Luciferin Potassium Salt: Illuminating Translational Front

  2026-05-14

  This thought-leadership article explores how D-Luciferin (potassium salt) empowers translational researchers with unprecedented precision for in vivo bioluminescence imaging, tumor cell tracking, and mechanistic discovery. Bridging foundational plant biology insights with cutting-edge preclinical oncology, the piece provides mechanistic clarity, workflow guidance, and a forward-looking perspective on how this bioluminescence imaging substrate is redefining translational research standards.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Studies

  2026-05-13

  Angiotensin I/II (1-5) offers researchers a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system, especially in cardiovascular and renal workflows. It should not be used for studies outside blood pressure regulation, aldosterone signaling, or related peptide hormone pathways due to its specific solubility and mechanistic profile.

• Magneto-Piezoelectric Scaffolds Target JAK2-STAT3 for Bone R

  2026-05-13

  This study introduces multifunctional scaffolds enhanced with magneto-piezoelectric nanoparticles targeting Icam1+ macrophages in infectious bone defects. By activating oxidative phosphorylation through the JAK2-STAT3 pathway and disrupting biofilms, the approach offers a dual strategy for infection control and bone regeneration.

• T-5224: C-Fos/AP-1 Inhibitor Empowering Neuroinflammation Re

  2026-05-12

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, delivers precise control of inflammation and osteoclastogenesis in both arthritis and neuroinflammatory models. This guide translates breakthrough workflows and troubleshooting strategies, directly informed by the latest mechanistic discoveries, to help researchers achieve publication-grade data.

16712 records 1/1115 page Next 12345 下5页 Last page